● Recruiting

Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution

Condition: Congenital Myasthenic Syndrome · Sponsor: The Foundation for Orthopaedics and Regenerative Medicine

PhasePhase 1

Planned participants20

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Patients with Congenital Myasthenic Syndrome will be treated with Mesenchymal Stem Cell Exosome solution.

This description comes directly from the study's public registry record.

Talk to the study team

Chadwick Prodromos · 18476996810 · care@thepsci.com

Always discuss trial participation with your own doctor first.

Locations (3)

Prodromos Stem Cell Institute	Naples, Florida, United States	Recruiting
Prodromos Stem Cell Institute	Irving, Texas, United States	Recruiting
Medical Surgical Associates Center	St John's, Antigua and Barbuda	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07226726